SBFM Volume dodolan mangsa ngarep perusahaan Sunshine Biopharma

SBFM (sunshinebiopharma.com) - tandha merek perusahaan

Diversification of raw material suppliers supports the margins of Sunshine Biopharma (SBFM), ensuring stability of deliveries to hospitals. Planned sales revenues visualize these trends, while 0.04 captures the current state of the parameter. Strict climate control during drug transportation guarantees their efficacy. Currently, generics drive the operating cash flow, while the potential of innovative macromolecules is expected in the future.

Prakiraan pendapatan perusahaan: Sunshine Biopharma (SBFM) kanggo 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar Sunshine Biopharma (SBFM)

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:SBFM Sunshine Biopharma, Inc.
Produk merek Sunshine Biopharma Inc.

Conservative capital demands maximum transparency regarding commercial prospects to minimize risks. This indicator measures the net monetization potential of assets, stripped of accounting distortions. For Sunshine Biopharma (SBFM), the calculation is based on the efficiency of outsourced development and testing. Such a model eliminates capital expenditures on manufacturing plants, focusing the valuation on future flows. Analyzing the organization's projected commercial revenue allows for the timely identification of stock overvaluation.

Karo sapa Sunshine Biopharma saingan

Prakiraan volume dodolan ONC|HALO (Halozyme) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan RVMD (revmed.com)|Dodolan mangsa ngarep perusahaan Ascentage (AAPG)|CGON: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan UroGen Pharma Ltd.|BCAX: Prakiraan volume dodolan|PSNL - Dodolan mangsa ngarep perusahaan|ERAS (Erasca Oncology) - Prakiraan volume dodolan|Prakiraan volume dodolan Delcath Systems, Inc.|Prakiraan pendapatan perusahaan ymabs.com (YMAB)|Prakiraan pendapatan perusahaan AURA (Aura Biosciences, Inc.)|Candel Therapeutics - Volume dodolan mangsa ngarep perusahaan|Accuray Inc. (ARAY) - Volume dodolan sing dikarepake perusahaan|SELLAS Life Sciences Group, Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan ACTU (Actuate Therapeutics, Inc.)|Citius Oncology (CTOR) - Prakiraan pendapatan perusahaan|HURA - Dodolan mangsa ngarep perusahaan|TARA (Protara Therapeutics, Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan Fate Therapeutics Inc|Prakiraan volume dodolan WHWK|Prakiraan volume dodolan TScan Therapeutics Inc (TCRX)|Prakiraan pendapatan perusahaan championsoncology.com CSBR|XBIT - Volume dodolan mangsa ngarep perusahaan|CVM - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan OSTX (OS Therapies)|RADX: Prakiraan volume dodolan|Artiva Biotherapeutics Inc. - Pendapatan mangsa ngarep perusahaan|ANL (Adlai Nortye) - Prakiraan volume dodolan|Prakiraan volume dodolan verupharma.com|Volume dodolan mangsa ngarep perusahaan TPST (tempesttx.com)|Volume dodolan mangsa ngarep perusahaan Xilio Therapeutics Inc XLO|Prakiraan volume dodolan RENB (Enochian BioSciences)|Mural Bio - Prakiraan pendapatan perusahaan|KAPA - Prakiraan pendapatan perusahaan|OnKure Therapeutics (OKUR) - Volume dodolan mangsa ngarep perusahaan|GDTC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Curis Corp (CRIS)|APLM (apollomicsinc.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Tharimmune Corp (THAR)|Prakiraan volume dodolan ADVB|GNPX - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan calidibio.com CLDI|Dodolan mangsa ngarep perusahaan Xenetic Biosciences (XBIO)|SLRX - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Kitov Pharma|AON (AONC) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan BeiGene|Prakiraan pendapatan perusahaan checkpointtx.com|Prakiraan pendapatan perusahaan ELEV (Elevation Oncology)|Prakiraan volume dodolan ICAD|Ikena Oncology - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Notable Labs, Ltd. NTBL|VIRX: Prakiraan pendapatan perusahaan|MOR - Prakiraan pendapatan perusahaan|NAYA Bio (NAYA) - Volume dodolan mangsa ngarep perusahaan|AAPGV: Prakiraan volume dodolan